News | September 12, 2022
Zenara Pharma launches the first generic of Paxlovid for COVID-19 in India
Pfizer’s Paxlovid is approved by US FDA for COVID treatment
Pfizer’s Paxlovid is approved by US FDA for COVID treatment
The approved product has an estimated market size of around US $62 million for the twelve months ending June 2022 according to IQVIA
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
The Congress was held on June, 20-21, 2022 in Berlin, Germany
The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger
Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profile
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
The proposed demerger is the most significant corporate change for GSK in the last 20 years
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19
Subscribe To Our Newsletter & Stay Updated
